Shares of Lupin today went up by over 2 per cent after the company said it has launched pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market.
The stock gained 2 per cent to settle at Rs 1,060.60 on BSE. During the day, it rose by 2.99 per cent to Rs 1,070.95.
Lupin was the best performer among the 30-share index.
At NSE, shares of the company advanced by 2.12 per cent to close at Rs 1,062.
In terms of equity volume, 1.34 lakh shares of the company were traded on BSE and over 24 lakh shares changed hands at NSE during the day.
The company has launched Hydrocodone Bitartrate and Acetaminophen tablets USP in the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval from the US Food and Drug Administration (USFDA), Lupin said in a BSE filing.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)